|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Sandvik AB (STO:SAND), a Swedish-based manufacturer of products using advanced stainless materials, special alloys, metallic and ceramic resistance materials. |
|---|---|
| Transferring Party | Doncasters Medical Technologies division (Doncastes Group Ltd UK), a contract manufacturer of orthopedic implants and instruments. |
| Sector | Medical Devices |
| Date | June 12, 2007 |
| Analysis Doncasters' implant business -- made of high-tech alloys -- supplements Sandvik's materials technology, manufacturing, and development capabilities. The new organization advances the goal of "end-to-end" services to OEMs of medical devices and instruments (from base material to finish products). Doncasters operates from sites across Europe, the U.S. and Mexico. Terms not disclosed; Doncasters' sales are $70m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |